GRIPonMASH, Author at GRIPonMASH

Successful Kick-off Meeting GRIPonMASH

Recap on the kick-off meeting in Seville (7 & 8 March) Last month, we convened the Kick-off Meeting in Seville. We commenced these days with introductions and outlined the project’s aims. Various partners delivered inspiring presentations, providing valuable insights. Moreover, it was a wonderful opportunity for everyone to meet face-to-face. Positive feedback attendees We had […]

GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)

New European project aims to improve tools and advice to prevent chronic liver illnesses. Utrecht, The Netherlands, 05-02-2024 GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Supported by the Innovative […]

Grant Agreement 101132946.

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132946. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, Efpia, EuropaBio, MedTech Europe, Vaccines Europe and Mercodia Aktiebolag, Metadeq Limited and Julius Clinical Research BV.

Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.